Pine Labs IPO GMP, Price, Allotment & Listing Date Details

The highly anticipated Pine Labs IPO has opened for subscription and is already creating buzz among investors. Known for its strong position in the fintech space, Pine Labs’ public issue is one of the major IPOs hitting the market in November 2025. Let’s explore all the key details, including Pine Labs IPO GMP, issue size, allotment date, and expected listing price.

Pine Labs IPO Details

Pine Labs IPO is a book-built issue amounting to ₹3,899.91 crores, consisting of a fresh issue of 9.41 crore shares worth ₹2,080 crores and an offer for sale (OFS) of 8.23 crore shares aggregating to ₹1,819.91 crores.

• IPO Opening Date: November 7, 2025

• IPO Closing Date: November 11, 2025

  
  

• Allotment Date: November 12, 2025

• Listing Date (Tentative): November 14, 2025

• Exchange: BSE, NSE

• Price Band: ₹210 – ₹221 per share

• Issue Size: ₹3,899.91 Crores

• Lot Size: 67 shares
  
  

For retail investors, the minimum investment is ₹14,807 for one lot (67 shares at the upper price band). For Small HNIs (sNII), the minimum lot size is 14 lots (938 shares) amounting to ₹2,07,298, and for Big HNIs (bNII), it is 68 lots (4,556 shares) amounting to ₹10,06,876.

Additionally, the IPO includes a reservation of 1,25,000 shares for employees at a discount of ₹21 per share to the issue price.

Pine Labs IPO GMP Today

As of November 10, 2025 (10:01 AM), the Pine Labs IPO GMP (Grey Market Premium) is ₹4. With a price band cap of ₹221, the estimated listing price stands at ₹225 per share, indicating an expected gain of 1.81%.

Here’s the latest subject to sauda data:

• Retail Subject to Sauda: ₹200

• Small HNI Subject to Sauda: ₹2,800

This shows that the grey market sentiment has turned slightly cautious, reflecting a mild premium before the listing.

Pine Labs IPO GMP Trend & Analysis

Based on the last nine sessions of grey market activity, the Pine Labs IPO GMP has shown a downward trend, suggesting a decline in speculative buying interest. The highest recorded GMP so far has been ₹60, while the lowest is ₹4, indicating notable volatility in sentiment.

Despite the short-term dip, Pine Labs continues to hold strong fundamentals. Its established digital payments ecosystem and consistent revenue growth could attract long-term investors even if the immediate grey market response remains subdued.

At Finowings, we provide daily GMP updates to help investors track real-time market sentiment, potential listing gains, and shifts in investor demand.

Expected Listing & Investment Outlook

The Pine Labs IPO is one of the most awaited fintech listings in recent years. While the current GMP of ₹4 indicates a modest listing premium, investor enthusiasm may pick up as institutional and retail subscription data becomes clearer.

Given the company’s diverse fintech portfolio, strong merchant base, and growing digital payment ecosystem, Pine Labs is well-positioned for long-term growth. Investors should watch for subscription numbers, QIB participation, and market conditions to better gauge potential listing-day performance.

Conclusion

The Pine Labs IPO GMP currently stands at ₹4, implying a marginal upside of around 1.81% from the upper price band. Although GMP trends have softened, the IPO’s large issue size, employee reservation, and strong business fundamentals make it a significant event in the Indian primary market.

Stay tuned with Finowings for daily Pine Labs IPO GMP updates, subscription insights, and expected listing price analysis to make informed investment decisions.